Developing the Dietary Inflammatory Index for Clinical Application

Completed · Not applicable

Conditions studied: Inflammation

In brief

Diet plays a central role in the regulation of chronic inflammation. However, until the investigators developed the dietary inflammatory index (DII) there had been no scientifically valid way to relate what individuals eat to the capacity of foods consumed to modulate inflammation. The DII provides a tool that will form the basis of a counseling/instructional system aimed at helping patients and their providers to control chronic, systemic inflammation by improving the diet with specific, actionable dietary recommendations, counseling, and expert instruction. The goal of this study is to test the applicability of a DII mobile tool and associated counseling measures in clinical practice.

Key facts

Study ID

NCT02382458

Run by

University of South Carolina

People needed

97

Starts

2015-05-01

Expected to finish

2017-12-31

Last updated by the study team

2019-04-18

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Are actively engaged as patients in the medical practices of University Specialty Clinics (under the direction of Dr. Victor Hirth) or Eau Claire Cooperative Health Care System (under the direction of Dr. Stuart Hamilton) or has physician consent
• Are ≥21 years of age;
• Are willing and able to participate fully in the study for a period of one year; and
• Are able to obtain travel to and from the intervention classes at the designated time.

You may not qualify if…

• Serious, unstable co-morbidity that would make participation in a diet and physical activity intervention difficult or risky including renal disease retinopathy, peripheral vascular disease or neuropathy;
• Any medications that are known to influence CRP levels such as chronic steroid (e.g., prednisone) use;
• Diagnoses of congestive heart failure, chronic renal failure, chronic liver disease (including alcoholic cirrhosis), cancer within the past year (except for non-melanoma skin cancer);
• Actively receiving cancer treatment;
• Have had any major surgeries in the past 3 months;
• Poor performance status according to the World Health Organization definitions (i.e., Level 3: symptomatic, >50% in bed, capable of only limited self-care; or Level 4: bedbound); or
• Life expectancy <3 years, on hospice, nursing home or other institutionalized care.

Where it is running

• University of South Carolina — Columbia, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.